Article

Anemia-Relieving Pharmacotherapies for Thalassemia: A Cross-Sectional Study of Clinical Trials from Clinicaltrials.gov

2026-05-29

Abstract excerpt

<title>Abstract</title> <p>Background Thalassemia is a prevalent inherited hematologic disorder imposing substantial health burdens, with unmet clinical needs for effective anemia-relieving therapies. Despite the rapid advancement of targeted drug development, systematic characterization of the global clinical trial landscape remains insufficient. Objective To examine the characteristics and publication status...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 02798c43-3adb-5202-aa5a-ced7d4c34be0
DOI: 10.21203/rs.3.rs-9775090/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Anemia-Relieving Pharmacotherapies for Thalassemia: A Cross-Sectional Study of Clinical Trials from Clinicaltrials.govDOI 10.21203/rs.3.rs-9775090/v1Read

2017 Clinical trials update in new treatments of β‐thalassemiaSemantic proximity Read

Defining curative endpoints for transfusion‐dependent β‐thalassemia in the era of gene therapy and gene editingSemantic proximity Read

Global Trends on β-thalassemia Research over 10 Years: A Bibliometric AnalysisSemantic proximity Read

Disease burden, management strategies, and unmet needs in α-thalassemia due to hemoglobin H disease.Semantic proximity Read

Epidemiology and treatment of beta thalassemia major in ChinaSemantic proximity Read

Pathophysiology and treatment of patients with beta-thalassemia – an updateSemantic proximity Read

Anemia: progress in molecular mechanisms and therapiesSemantic proximity Read

Thalassemia an update: molecular basis, clinical features and treatmentSemantic proximity Read

Beta thalassemia syndromes: New insightsSemantic proximity Read

Pharmacological and molecular approaches for the treatment of β-hemoglobin disorders.Semantic proximity Read

New therapeutic targets in transfusion-dependent and -independent thalassemia.Semantic proximity Read

[Clinical practice guidelines for alpha-thalassemia].Semantic proximity Read